Jiunn‐Kae Chang

926 total citations
14 papers, 818 citations indexed

About

Jiunn‐Kae Chang is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Jiunn‐Kae Chang has authored 14 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Jiunn‐Kae Chang's work include Bone Metabolism and Diseases (4 papers), Cell death mechanisms and regulation (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Jiunn‐Kae Chang is often cited by papers focused on Bone Metabolism and Diseases (4 papers), Cell death mechanisms and regulation (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Jiunn‐Kae Chang collaborates with scholars based in Taiwan, United States and Canada. Jiunn‐Kae Chang's co-authors include Po‐Lin Kuo, Ya‐Ling Hsu, Cheng‐Hsiung Chang, Clay C. C. Wang, Yi‐Ming Chiang, Min‐Da Shau, Mei‐Fen Shih, Jong‐Yuh Cherng, Jui‐Kun Chiang and Malcolm Koo and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, International Journal of Pharmaceutics and Biochemical Pharmacology.

In The Last Decade

Jiunn‐Kae Chang

14 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiunn‐Kae Chang Taiwan 13 361 159 130 98 83 14 818
Marwa Sharaky Egypt 15 262 0.7× 53 0.3× 272 2.1× 64 0.7× 42 0.5× 78 892
T. R. Santhosh Kumar India 19 484 1.3× 22 0.1× 59 0.5× 101 1.0× 86 1.0× 40 992
Hugues Malonne Belgium 11 274 0.8× 64 0.4× 82 0.6× 96 1.0× 45 0.5× 21 617
Mathew George India 6 280 0.8× 20 0.1× 82 0.6× 47 0.5× 68 0.8× 23 751
Sivanantham Banudevi India 16 353 1.0× 23 0.1× 61 0.5× 151 1.5× 48 0.6× 19 1.0k
Deborah Finucane Ireland 6 356 1.0× 33 0.2× 81 0.6× 81 0.8× 15 0.2× 12 724
Kanwal Ahmed Japan 18 347 1.0× 40 0.3× 115 0.9× 95 1.0× 78 0.9× 26 819
Kuan Liu China 12 430 1.2× 30 0.2× 83 0.6× 109 1.1× 31 0.4× 29 1.0k
Ruoqiu Fu China 15 498 1.4× 22 0.1× 72 0.6× 270 2.8× 49 0.6× 26 1.2k

Countries citing papers authored by Jiunn‐Kae Chang

Since Specialization
Citations

This map shows the geographic impact of Jiunn‐Kae Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiunn‐Kae Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiunn‐Kae Chang more than expected).

Fields of papers citing papers by Jiunn‐Kae Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiunn‐Kae Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiunn‐Kae Chang. The network helps show where Jiunn‐Kae Chang may publish in the future.

Co-authorship network of co-authors of Jiunn‐Kae Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiunn‐Kae Chang. A scholar is included among the top collaborators of Jiunn‐Kae Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiunn‐Kae Chang. Jiunn‐Kae Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Chang, Jiunn‐Kae, et al.. (2012). Association of sleep duration and insulin resistance in Taiwanese vegetarians. BMC Public Health. 12(1). 666–666. 14 indexed citations
2.
Chiang, Jui‐Kun, Ning‐Sheng Lai, Jiunn‐Kae Chang, & Malcolm Koo. (2011). Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults. Cardiovascular Diabetology. 10(1). 93–93. 71 indexed citations
3.
Chang, Jiunn‐Kae, et al.. (2009). Synthesis and Characterizations of New Lysine-Based Biodegradable Cationic Poly(urethane-co-ester) and Study on Self-Assembled Nanoparticles with DNA. Bioconjugate Chemistry. 20(4). 774–779. 15 indexed citations
4.
Wang, Clay C. C., Yi‐Ming Chiang, Po‐Lin Kuo, Jiunn‐Kae Chang, & Ya‐Ling Hsu. (2008). NORSOLORINIC ACID INHIBITS PROLIFERATION OF T24 HUMAN BLADDER CANCER CELLS BY ARRESTING THE CELL CYCLE AT THE G0/G1 PHASE AND INDUCING A FAS/MEMBRANE‐BOUND FAS LIGAND‐MEDIATED APOPTOTIC PATHWAY. Clinical and Experimental Pharmacology and Physiology. 35(11). 1301–1308. 11 indexed citations
5.
Wang, Clay C. C., Yi‐Ming Chiang, Po‐Lin Kuo, Jiunn‐Kae Chang, & Ya‐Ling Hsu. (2008). Norsolorinic Acid from Aspergillus nidulans Inhibits the Proliferation of Human Breast Adenocarcinoma MCF‐7 Cells via Fas‐Mediated Pathway. Basic & Clinical Pharmacology & Toxicology. 102(6). 491–497. 14 indexed citations
6.
Shen, Kun‐Hung, Jiunn‐Kae Chang, Ya‐Ling Hsu, & Po‐Lin Kuo. (2007). Chalcone Arrests Cell Cycle Progression and Induces Apoptosis through Induction of Mitochondrial Pathway and Inhibition of Nuclear Factor Kappa B Signalling in Human Bladder Cancer Cells. Basic & Clinical Pharmacology & Toxicology. 101(4). 254–261. 75 indexed citations
8.
Kuo, Po‐Lin, Yu‐Ting Huang, Cheng‐Hsiung Chang, & Jiunn‐Kae Chang. (2006). Bone Morphogenetic Protein-2 and -4 (BMP-2 and -4) Mediates Fraxetin-Induced Maturation and Differentiation in Human Osteoblast-Like Cell Lines. Biological and Pharmaceutical Bulletin. 29(1). 119–124. 25 indexed citations
9.
Shih, Mei‐Fen, et al.. (2006). Platelet adsorption and hemolytic properties of liquid crystal/composite polymers. International Journal of Pharmaceutics. 327(1-2). 117–125. 149 indexed citations
10.
Chang, Jiunn‐Kae, et al.. (2006). Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production. European Journal of Pharmacology. 551(1-3). 1–9. 37 indexed citations
11.
Hsu, Ya‐Ling, et al.. (2006). Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. Biochemical Pharmacology. 73(4). 504–514. 71 indexed citations
12.
Kuo, Po‐Lin, Yu‐Ting Huang, Cheng‐Hsiung Chang, & Jiunn‐Kae Chang. (2006). Fraxetin inhibits the induction of anti-Fas IgM, tumor necrosis factor-α and interleukin-1β-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63. International Immunopharmacology. 6(7). 1167–1175. 14 indexed citations
13.
Kuo, Po‐Lin, Ya‐Ling Hsu, Ta‐Chen Lin, Jiunn‐Kae Chang, & Chun‐Ching Lin. (2005). Induction of cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells by casuarinin from the bark of Terminalia arjuna Linn.. Anti-Cancer Drugs. 16(4). 409–415. 36 indexed citations
14.
Kuo, Po‐Lin, Ya‐Ling Hsu, Cheng‐Hsiung Chang, & Jiunn‐Kae Chang. (2005). Osthole-Mediated Cell Differentiation through Bone Morphogenetic Protein-2/p38 and Extracellular Signal-Regulated Kinase 1/2 Pathway in Human Osteoblast Cells. Journal of Pharmacology and Experimental Therapeutics. 314(3). 1290–1299. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026